Developing a pipeline of small molecule therapeutics for patients with immunological and genetic disorders.
We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
Leading angel networks in Oxford merge to catalyse early-stage tech investment in the Oxford Cluster.
Y Combinator startup Prolific announces $1.2M seed round with participation from Pioneer Fund and prominent Silicon Valley Angel investors.
New virtual reality medical training app LIFE uses HTC VIVE Focus Plus for training doctors and nurses to save lives.
Oxford spinout developing novel therapeutics based on deep expertise in immune cell regulation.
MoA Technology, borne out of Oxford University research, launches to confront the global herbicide resistance crisis with £6.3m Series A funding round.
Oxford Brain Diagnostics sets out with the goal of improving the treatment of Alzheimer’s by enabling early and accurate detection
The Oxford University spinout company launches to look inside the brain for novel markers of disease.